Literature DB >> 17198968

China's unique position in discovery and preclinical research.

Roman Boutellier1, Fredrik Ullman.   

Abstract

Mesh:

Year:  2006        PMID: 17198968     DOI: 10.1016/j.drudis.2006.11.009

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


× No keyword cloud information.
  1 in total

1.  Contract Research Organizations (CROs) in China: integrating Chinese research and development capabilities for global drug innovation.

Authors:  Yun-Zhen Shi; Hao Hu; Chunming Wang
Journal:  Global Health       Date:  2014-11-19       Impact factor: 4.185

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.